nifedipine has been researched along with Dyskinesia, Drug-Induced in 10 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
Dyskinesia, Drug-Induced: Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199)
| Excerpt | Relevance | Reference |
|---|---|---|
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 9.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 9.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 5.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| "We investigated the efficacy of nilvadipine, a calcium channel inhibitor, for psychiatric symptoms and tardive dyskinesia in 30 patients with chronic schizophrenia in a placebo-controlled double-blind crossover study." | 5.08 | Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. ( Asai, M; Ashikari, I; Kanba, S; Ohnishi, K; Yagi, G; Yamada, K, 1996) |
| "We examined whether nifedipine, a calcium channel antagonist, added to a stable regimen of neuroleptic medication would affect cognition in patients with chronic schizophrenia or schizoaffective disorder who had tardive dyskinesia." | 5.08 | Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia. ( Deutsch, SI; Fay-McCarthy, M; Kendrick, K; Rosse, RB; Schwartz, BL, 1997) |
| "In an open label study, two fixed doses of nifedipine (30 mg and 60 mg daily) were added to the usual antipsychotic drug treatments of 10 patients suffering from chronic schizophrenia." | 5.07 | Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients. ( Eyles, D; Pond, SM; Stedman, TJ; Welham, JL; Whiteford, HA, 1991) |
| "Effects of the dihydropyridine calcium channel inhibitor nifedipine on chronic schizophrenia and tardive dyskinesia were studied in an 8-week double-blind crossover trial." | 5.07 | A clinical trial of nifedipine in schizophrenia and tardive dyskinesia. ( Bigelow, LB; Freed, WJ; Kirch, DG; Straw, GM; Suddath, RL; Wyatt, RJ, 1991) |
| "Nilvadipine is a calcium channel inhibitor used commonly for the treatment of cerebrovascular insufficiency." | 1.29 | Effectiveness of nilvadipine in two cases of chronic schizophrenia. ( Asai, M; Ashikari, I; Kanba, S; Onishi, K; Yagi, G; Yamada, K, 1995) |
| "Nifedipine treatment resulted in variable improvement in tardive dyskinesia in eight geriatric psychiatric patients." | 1.28 | Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients. ( Kushnir, SL; Ratner, JT, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 7 (70.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cates, M | 1 |
| Lusk, K | 1 |
| Wells, BG | 1 |
| Yamada, K | 2 |
| Kanba, S | 2 |
| Ashikari, I | 2 |
| Ohnishi, K | 1 |
| Yagi, G | 2 |
| Asai, M | 2 |
| Onishi, K | 1 |
| Schwartz, BL | 1 |
| Fay-McCarthy, M | 1 |
| Kendrick, K | 1 |
| Rosse, RB | 1 |
| Deutsch, SI | 1 |
| Soares, KV | 1 |
| McGrath, JJ | 1 |
| Stedman, TJ | 1 |
| Whiteford, HA | 1 |
| Eyles, D | 1 |
| Welham, JL | 1 |
| Pond, SM | 1 |
| Suddath, RL | 1 |
| Straw, GM | 1 |
| Freed, WJ | 2 |
| Bigelow, LB | 1 |
| Kirch, DG | 1 |
| Wyatt, RJ | 1 |
| Duncan, E | 1 |
| Adler, L | 1 |
| Angrist, B | 1 |
| Rotrosen, J | 1 |
| Cadet, JL | 1 |
| Taylor, E | 1 |
| Kushnir, SL | 1 |
| Ratner, JT | 1 |
2 reviews available for nifedipine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Are calcium-channel blockers effective in the treatment of tardive dyskinesia?
Topics: Aged; Aged, 80 and over; Calcium Channel Blockers; Clinical Trials as Topic; Diltiazem; Dyskinesia, | 1993 |
Diltiazem, nifedipine, nimodipine or verapamil for neuroleptic-induced tardive dyskinesia.
Topics: Antipsychotic Agents; Calcium Channel Blockers; Diltiazem; Dyskinesia, Drug-Induced; Humans; Nifedip | 2000 |
5 trials available for nifedipine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off.
Topics: Adult; Aged; Calcium Channel Blockers; Chronic Disease; Cross-Over Studies; Double-Blind Method; Dys | 1996 |
Effects of nifedipine, a calcium channel antagonist, on cognitive function in schizophrenic patients with tardive dyskinesia.
Topics: Aged; Calcium Channel Blockers; Cognition; Cross-Over Studies; Double-Blind Method; Dyskinesia, Drug | 1997 |
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
Topics: Adult; Antipsychotic Agents; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Haloperido | 1991 |
A clinical trial of nifedipine in schizophrenia and tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Benztropine; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Hum | 1991 |
Nifedipine in the treatment of tardive dyskinesia.
Topics: Adult; Antipsychotic Agents; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Neurologic Examina | 1990 |
3 other studies available for nifedipine and Dyskinesia, Drug-Induced
| Article | Year |
|---|---|
Effectiveness of nilvadipine in two cases of chronic schizophrenia.
Topics: Calcium Channel Blockers; Chronic Disease; Dyskinesia, Drug-Induced; Humans; Male; Middle Aged; Nife | 1995 |
The iminodipropionitrile (IDPN)-induced dyskinetic syndrome in mice: antagonism by the calcium channel antagonist nifedipine.
Topics: Animals; Binding Sites; Brain; Calcium; Dihydropyridines; Dyskinesia, Drug-Induced; Female; Ion Chan | 1988 |
Calcium channel blockers for tardive dyskinesia in geriatric psychiatric patients.
Topics: Age Factors; Aged; Aged, 80 and over; Dyskinesia, Drug-Induced; Female; Humans; Hypertension; Male; | 1989 |